Minerals Technologies (MTX) J.P. Morgan 2026 Global Leveraged Finance Conference summary
Event summary combining transcript, slides, and related documents.
J.P. Morgan 2026 Global Leveraged Finance Conference summary
3 Mar, 2026Company overview and market positioning
Operates globally with over $2 billion in sales, 4,000 employees, and 146 locations across 34 countries.
Focuses on specialty minerals, primarily bentonite and calcium carbonate, with leading market positions.
Balanced portfolio: about half consumer-oriented (pet litter, food, pharmaceuticals), half industrial (steel, foundry, construction).
Four main product lines: Household & Personal Care, Specialty Additives, High-Temperature Technologies, and Environmental & Infrastructure.
56% of sales in North America, 24% EMEA, 17% Asia.
Growth drivers and innovation
Growth driven by sustainable solutions, natural ingredients, and technology-enhanced minerals.
Pet litter business expanded from $70M to $400M in 5-6 years, with private label outpacing branded growth.
Specialty products like bleaching earth for edible oils and sustainable aviation fuel growing at 15% annually.
High-Temperature Technologies benefiting from innovations like MINSCAN LSC for electric arc furnaces.
Environmental & Infrastructure segment growing via PFAS water remediation and offshore oil/gas water treatment.
Financial performance and capital allocation
Maintains strong liquidity ($724M), net leverage at 1.7x, and consistent free cash flow conversion (6%-7% of sales).
Capital deployment: 50% of free cash flow to shareholders (buybacks/dividends), 50% reserved for inorganic growth.
Investments in 2023 (~$50M) expected to generate $100M in annualized revenue, supporting mid-single-digit growth in 2024.
Achieved 15% operating income margin in 2023; targets for 10% operating income growth and 7% free cash flow of sales.
Organic sales growth target of 5% delayed by about a year due to market cyclicality.
Latest events from Minerals Technologies
- Record adjusted EPS and operating income, with strong margins and robust free cash flow.MTX
Q2 20242 Feb 2026 - Adjusted EPS was $5.52 in 2025, with strong cash flow and growth expected in 2026.MTX
Q4 202530 Jan 2026 - Unified global branding, innovation, and sustainability drive growth and new market opportunities.MTX
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Record Q3 results, margin expansion, and new $200M buyback underscore strong capital returns.MTX
Q3 202418 Jan 2026 - Record financials and strong growth in consumer products set the stage for a robust 2025.MTX
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025 - $215M talc reserve drove a $144M Q1 loss, but Q2 is expected to improve.MTX
Q1 202524 Dec 2025 - Record margin and earnings growth in 2024, with strong cash flow and positive 2025 outlook.MTX
Q4 202415 Dec 2025 - Record financials, strong ESG progress, and board diversity highlight this year's proxy.MTX
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, all board-backed.MTX
Proxy Filing1 Dec 2025